Company Overview

Nutranomics, Inc. (OTC: NNRX) is a publicly traded company focused on health, wellness, nutraceutical, and consumer product markets. Based on public disclosures and OTC market filings, the company has pursued business activities involving nutraceutical products, wellness-focused formulations, and acquisitions intended to expand its operational footprint in consumer health and related sectors. The company has also been associated with hemp-derived and cannabidiol (CBD)-related product initiatives during portions of its operating history, reflecting broader trends in alternative wellness products and functional consumer goods.

The company’s business model has historically centered on developing or acquiring operating businesses capable of generating revenue through branded wellness products, distribution relationships, and retail-oriented consumer channels. Publicly available information indicates that Nutranomics has undergone multiple strategic shifts over time, including restructuring efforts and acquisition-driven expansion strategies. Some operational details and current commercial scale remain limited in public filings, and certain historical disclosures are not consistently updated across available public sources. Data inconclusive based on available public sources.

Business Operations

Nutranomics has historically organized operations around wellness and consumer-product activities, including nutraceutical formulations, hemp-derived products, and related distribution channels. Public disclosures reference operational interests tied to product manufacturing, branding, and sales partnerships. Revenue generation has primarily been associated with product sales, licensing arrangements, and acquisition-related business consolidation efforts. The company has also referenced efforts to integrate acquired operations into broader consumer wellness initiatives.

The company’s filings and public statements indicate exposure to both domestic U.S. markets and broader international sourcing or partnership activity, although the scale and continuity of these operations are not always clearly detailed in current disclosures. Nutranomics has announced relationships with subsidiaries and acquired entities in past periods; however, public reporting on the current operational status of several entities is limited. Data inconclusive based on available public sources.

Strategic Position & Investments

Nutranomics has historically pursued a growth strategy centered on acquisitions, wellness-sector expansion, and participation in emerging consumer health categories. Public announcements and filings have referenced strategic investments intended to broaden product offerings and improve distribution capabilities. The company has also explored opportunities connected to hemp-derived wellness products and nutraceutical innovation, positioning itself within higher-growth segments of the alternative health market.

The company’s strategic direction appears to emphasize portfolio diversification through acquisitions and operational integration. Public records reference involvement with acquired businesses and subsidiaries connected to wellness products, consumer goods, and distribution operations. However, independent verification of the financial performance and operational scale of several investments remains limited due to sparse or inconsistent updated reporting. Data inconclusive based on available public sources.

Geographic Footprint

Nutranomics is headquartered in the United States and has primarily focused on the North American market through consumer wellness and nutraceutical activities. Public disclosures indicate efforts to establish broader sourcing, manufacturing, and distribution relationships extending beyond domestic operations, including references to international commercial relationships associated with wellness and hemp-related supply chains.

The company’s market presence appears concentrated in the United States, with varying levels of reported international engagement over time. Publicly available information does not consistently provide detailed geographic revenue segmentation or operational breakdowns by region. As a result, the precise extent of current international operations and investment influence cannot be fully verified from available public sources.

Leadership & Governance

Nutranomics has experienced multiple leadership and organizational changes during its operating history, consistent with its acquisition-focused and restructuring-oriented business strategy. Public filings and OTC disclosures identify executive leadership responsible for corporate strategy, financing initiatives, and operational oversight. Due to variations in disclosure timing across public records, some executive and governance information may not reflect the company’s most current organizational structure.

Key executives identified in public disclosures include:

• Brian Shibley – Chief Executive Officer
• Michael Cavanaugh – Executive leadership role referenced in historical company disclosures
• Additional executive and board information – Data inconclusive based on available public sources.

The company’s leadership strategy has generally emphasized acquisition-led growth, expansion within wellness-oriented consumer categories, and efforts to build vertically integrated operations tied to nutraceutical and hemp-related products. Public filings, including SEC filings and OTC disclosures, provide limited but recurring references to these strategic priorities.